Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1
- PMID: 7676619
- DOI: 10.1006/viro.1995.1458
Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1
Abstract
The PE2 cleavage signal in a full-length cDNA clone of the alphavirus Venezuelan equine encephalitis virus (VEE) was ablated by site-directed mutagenesis. RNA transcripts derived from the resulting plasmids programmed the production of nonviable particles upon transfection of baby hamster kidney (BHK) cells. However, the mutant RNAs also gave rise to a small proportion of viable revertants. Analysis of these biological revertants and their molecularly cloned homologs demonstrated that second-site suppressor mutations at either E2 position 243 or E1 position 253 were able to restore viability to PE2 cleavage signal mutants. The viable revertants incorporated unprocessed PE2 into particles which showed normal infectivity for BHK cells, but reduced ability to grow in C6/36 mosquito cells. A mutant carrying a lethal PE2 cleavage signal mutation in combination with a suppressor at E1 253 was either avirulent or highly attenuated in adult mice when inoculated by the subcutaneous, intracerebral, or intranasal route and conferred complete protection against both intraperitoneal and intranasal challenge with virulent VEE. These results indicate the close functional association of the E2 and E1 proteins in the alphavirus spike. They also have implications for the design of recombinant live virus vaccines for VEE, for other alphaviruses, and for other viruses that use a similar mechanism for glycoprotein maturation.
Similar articles
-
A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.Virology. 2000 Apr 25;270(1):111-23. doi: 10.1006/viro.2000.0241. Virology. 2000. PMID: 10772984
-
Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.Virology. 1995 Feb 1;206(2):994-1006. doi: 10.1006/viro.1995.1022. Virology. 1995. PMID: 7856110
-
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.Virology. 1997 Dec 22;239(2):389-401. doi: 10.1006/viro.1997.8878. Virology. 1997. PMID: 9434729
-
Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.Am J Trop Med Hyg. 2003 Feb;68(2):218-21. Am J Trop Med Hyg. 2003. PMID: 12641414
-
Alphavirus replicon particles as candidate HIV vaccines.IUBMB Life. 2002 Apr-May;53(4-5):209-11. doi: 10.1080/15216540212657. IUBMB Life. 2002. PMID: 12120997 Review.
Cited by
-
IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.Virology. 2013 Mar 15;437(2):81-8. doi: 10.1016/j.virol.2012.11.013. Epub 2013 Jan 22. Virology. 2013. PMID: 23351391 Free PMC article.
-
A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo.PLoS Pathog. 2007 Dec;3(12):e199. doi: 10.1371/journal.ppat.0030199. PLoS Pathog. 2007. PMID: 18215114 Free PMC article.
-
A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).J Virol Methods. 2010 Feb;163(2):424-32. doi: 10.1016/j.jviromet.2009.11.006. Epub 2009 Nov 10. J Virol Methods. 2010. PMID: 19903494 Free PMC article.
-
Venezuelan Equine Encephalitis Virus V3526 Vaccine RNA-Dependent RNA Polymerase Mutants Increase Vaccine Safety Through Restricted Tissue Tropism in a Murine Model.Zoonoses. 2022;2:2. doi: 10.15212/zoonoses-2021-0016. Epub 2022 Jan 13. Zoonoses. 2022. PMID: 35262074 Free PMC article.
-
Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.Viruses. 2019 Feb 18;11(2):164. doi: 10.3390/v11020164. Viruses. 2019. PMID: 30781656 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources